[1]
2021. Efficacy and safety of tralokinumab plus topical corticosteroids in patients with severe atopic dermatitis and prior history of dupilumab treatment: a post hoc subgroup analysis from ECZTRA 7 trial. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s60. DOI:https://doi.org/10.25251/skin.5.supp.60.